A Study to Assess the Safety and Efficacy of LB1410 in Participants With Advanced Solid Tumor or Lymphoma（Keyplus-001）
Clinical trial NCT05357651 · RECRUITING
Trial details
- NCT number
- NCT05357651
- Sponsor
- L & L Bio Co., Ltd., Ningbo, China
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-12
- Primary completion
- 2026-12-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.